Key result
A multivirus spike approach using TaqMan assays demonstrated highly comparable viral and host cell DNA clearance to a single virus spike approach, offering significant time and cost savings.
A multivirus spike approach using quantitative PCR provides comparable viral clearance evaluation to single virus spiking, offering significant time and cost savings for biologic drug development.
May streamline viral clearance testing in biologics manufacturing; leaves open regulatory adoption pending validation studies.
Viral contamination is a common risk to continuous cell line-derived biologics. Viral validation is thus required for license applications. Viral validation for chromatography procedures is routinely performed by spiking a model virus into the load material and performing the chromatography procedures at small scale under conditions equivalent to the commercial scale. With traditional cell-based infectivity assays, one can only spike one model virus at one time. Quantitative PCR methods (TaqMan) make it possible to spike multiple model viruses for a chromatography procedure simultaneously. TaqMan assays can quantify multiple types of viruses and other types of nucleic acid in a single sample without cross interference because of its extremely high specificity. Therefore, a multivirus spike approach was evaluated and compared to a single virus spike approach. The study was further extended to the evaluation of host cell DNA clearance. The data shows highly comparable viral and host cell DNA clearance between the single and multiple virus spike approaches. Application of a multivirus spike approach provides significant time, manpower, and cost savings for new drug development.
No takes yet. Share an insight, caveat, or question.
Valera et al. (2003) studied Viral contamination in continuous cell line-derived biologics. Multivirus spike approach using Quantitative PCR (TaqMan) vs. Single virus spike approach was evaluated on Viral and host cell DNA clearance. A multivirus spike approach using TaqMan assays demonstrated highly comparable viral and host cell DNA clearance to a single virus spike approach, offering significant time and cost savings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: